
CMVLF
Healthcare · Biotechnology · $99.9M market cap
$0.99200.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 11, 2026 | After the close | — | -0.22 | — |
| May 11, 2026 | After the close | — | -0.18 | — |
| Mar 19, 2026 | After the close | — | -0.26 | — |
| Nov 7, 2025 | After the close | — | 0.01 | — |
| Aug 4, 2025 | After the close | — | -0.24 | — |
| Nov 4, 2024 | After the close | — | -0.23 | — |
| Aug 6, 2024 | Before the open | — | -0.28 | — |
| May 28, 2024 | Before the open | — | 0.05 | — |
| Mar 13, 2024 | After the close | — | -0.64 | — |
| Mar 8, 2023 | After the close | -0.81 | -0.58 | +28.4% |
| Nov 3, 2022 | After the close | -0.54 | -0.63 | -16.7% |
| Aug 4, 2022 | After the close | -0.68 | -0.42 | +38.2% |
| May 12, 2022 | After the close | -0.64 | -0.62 | +3.1% |
Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing BALLI-01, to evaluate the safety, expansion, persistence, and clinical activities of lasme-cel in patients…
| After the close |
| -1.10 |
| -0.48 |
| +56.4% |
| Nov 4, 2021 | After the close | -0.55 | -0.71 | -29.1% |
| Aug 5, 2021 | After the close | -0.60 | -0.73 | -21.7% |
| May 6, 2021 | After the close | — | -0.88 | — |
| Mar 4, 2021 | After the close | — | -0.28 | — |
| Nov 5, 2020 | After the close | — | -0.93 | — |
| Jul 22, 2020 | Time not confirmed | — | -0.71 | — |
| May 6, 2020 | After the close | — | -0.76 | — |
| Mar 4, 2020 | After the close | — | 0.47 | — |
| Nov 13, 2019 | After the close | — | -0.89 | — |
| Aug 7, 2019 | Before the open | — | -0.38 | — |
| May 7, 2019 | After the close | — | -0.79 | — |
| Mar 11, 2019 | After the close | — | -0.36 | — |
| Nov 13, 2018 | After the close | — | -0.55 | — |
| Aug 1, 2018 | After the close | — | -0.54 | — |
| May 7, 2018 | After the close | — | -0.17 | — |
| Mar 12, 2018 | After the close | — | -0.71 | — |